patients with SjS can develop myelopathy without HTLV-1 infection. Ironically, patients with SjS would not usually be tested for HTLV-1 unless myelopathy occurred and patients with HTLV-1 infection would not be tested for SjS unless myelopathy occurred; some patients with SjS test negative for anti-SSA or anti-SSB autoantibodies and may lead to a negative diagnosis when SjS is present.
In one study [11] , of ten patients presenting with HTLV-1 associated myelopathy (HAM), six were diagnosed with SjS and two were suspected to have it. Since all of the HAM patients also showed lymphocytic infiltration in the salivary glands (whether anti-SSA or anti-SSB autoantibodies were present), it becomes difficult to diagnose SjS as that is one of the qualifying criteria. Either salivary gland infiltration is a symptom of HTLV-1 associated exclusively to HAM, or SjS patients exclusively exhibit HAM. Further examination and larger cohorts of patients would be necessary to confirm which of these two options is correct.
Use of animal models is another viable option for studying this relationship. In one transgenic rat model (HTLV-1 env-pX), the env-pX gene was inserted into the WKAH strain [14] and rats developed SjS-like symptoms along with an array of other symptoms characteristic of autoimmune diseases [15] , but manifestation of myelopathy was not studied. Further examination of this line, focusing on myelopathy exclusively may yield an answer as to whether or not HAM is present only in SjS patients, but this may be difficult as they are prone to developing other autoimmune disorders. Complexing SjS with another autoimmune disorder may convolute the findings as they may either exacerbate or mask symptoms.
To further understand HAM moving forward, it will probably become necessary to correctly diagnose patients with or without SjS. For HAM in SjS patients combined treatment with a corticosteroid and anti-viral has shown improvement in the patients' condition without resolving the lesion [16] ; reversal of parathesia, numbness, pain or paraplegia may occur. Further examination of HAM both in a clinical setting and utilizing animal models may be necessary to fully understand if and why HAM presents exclusively in SjS patients.
